Innovative MedTech Inc. (IMTH)
USD 0.58
(34.88%)
USD 0.58
(34.88%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 651.88 Thousand USD | -85.35% |
| 2023 | 4.44 Million USD | -7.3% |
| 2022 | 4.8 Million USD | -8.46% |
| 2021 | 5.24 Million USD | 684480.16% |
| 2020 | 766.00 USD | 8411.11% |
| 2019 | 9.00 USD | 0.0% |
| 2014 | 608.00 USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | -100.0% |
| 2011 | 86.03 Thousand USD | -52.59% |
| 2010 | 181.48 Thousand USD | 106.87% |
| 2009 | 87.72 Thousand USD | -57.59% |
| 2008 | 206.87 Thousand USD | -45.23% |
| 2007 | 377.74 Thousand USD | 28.34% |
| 2006 | 294.32 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 4.57 Million USD | 2.74% |
| 2024 Q2 | 4.32 Million USD | -5.29% |
| 2024 Q3 | 4.65 Million USD | 7.6% |
| 2024 Q4 | 651.88 Thousand USD | -86.01% |
| 2023 FY | 4.44 Million USD | -7.3% |
| 2023 Q4 | 4.44 Million USD | -1.39% |
| 2023 Q1 | 4.58 Million USD | -4.44% |
| 2023 Q2 | 4.5 Million USD | -1.88% |
| 2023 Q3 | 4.51 Million USD | 0.26% |
| 2022 Q4 | 4.8 Million USD | -3.77% |
| 2022 FY | 4.8 Million USD | -8.46% |
| 2022 Q3 | 4.98 Million USD | 4.06% |
| 2022 Q2 | 4.79 Million USD | -2.86% |
| 2022 Q1 | 4.93 Million USD | -5.91% |
| 2021 Q3 | 6.04 Million USD | 0.0% |
| 2021 FY | 5.24 Million USD | 684480.16% |
| 2021 Q1 | - USD | 0.0% |
| 2021 Q4 | 5.24 Million USD | -13.24% |
| 2020 FY | 766.00 USD | 8411.11% |
| 2019 FY | 9.00 USD | 0.0% |
| 2015 Q1 | 608.00 USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 FY | 608.00 USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | -100.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2012 Q1 | 86.03 Thousand USD | 51.92% |
| 2012 Q2 | 83.59 Thousand USD | -2.83% |
| 2012 Q3 | 187.4 Thousand USD | 124.17% |
| 2012 Q4 | 120.32 Thousand USD | -35.79% |
| 2012 FY | - USD | -100.0% |
| 2011 FY | 86.03 Thousand USD | -52.59% |
| 2011 Q2 | 105.41 Thousand USD | -41.91% |
| 2011 Q3 | 79.84 Thousand USD | -24.26% |
| 2011 Q4 | 56.63 Thousand USD | -29.07% |
| 2011 Q1 | 181.48 Thousand USD | -55.47% |
| 2010 FY | 181.48 Thousand USD | 106.87% |
| 2010 Q2 | 97.51 Thousand USD | 11.16% |
| 2010 Q1 | 87.72 Thousand USD | -45.49% |
| 2010 Q3 | 487.13 Thousand USD | 399.55% |
| 2010 Q4 | 407.57 Thousand USD | -16.33% |
| 2009 Q3 | 152.19 Thousand USD | -9.79% |
| 2009 FY | 87.72 Thousand USD | -57.59% |
| 2009 Q4 | 160.94 Thousand USD | 5.75% |
| 2009 Q1 | 206.87 Thousand USD | -10.07% |
| 2009 Q2 | 168.7 Thousand USD | -18.45% |
| 2008 Q2 | 312.54 Thousand USD | -17.26% |
| 2008 Q4 | 230.03 Thousand USD | -0.69% |
| 2008 FY | 206.87 Thousand USD | -45.23% |
| 2008 Q1 | 377.74 Thousand USD | -25.15% |
| 2008 Q3 | 231.62 Thousand USD | -25.89% |
| 2007 Q2 | 333.57 Thousand USD | 13.33% |
| 2007 Q3 | 305.98 Thousand USD | -8.27% |
| 2007 FY | 377.74 Thousand USD | 28.34% |
| 2007 Q4 | 504.66 Thousand USD | 64.93% |
| 2007 Q1 | 294.32 Thousand USD | 24.58% |
| 2006 Q3 | 555.00 USD | -98.55% |
| 2006 Q2 | 38.35 Thousand USD | 0.0% |
| 2006 Q4 | 236.25 Thousand USD | 42468.47% |
| 2006 FY | 294.32 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.83 Million USD | 64.534% |
| Ansell Limited | 3.23 Billion USD | 99.98% |
| Ansell Limited | 3.24 Billion USD | 99.98% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 488.98 Million USD | 99.867% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 300.36 Thousand USD | -117.032% |
| Psykey, Inc. | 1.72 Million USD | 62.261% |
| ConvaTec Group Plc | 3.7 Billion USD | 99.982% |
| ConvaTec Group Plc | 3.71 Billion USD | 99.982% |
| Encision Inc. | 3.81 Million USD | 82.893% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| LifePoint, Inc. | 8.8 Million USD | 92.6% |
| Medite Cancer Diagnostics, Inc. | 15.95 Million USD | 95.915% |
| Paradigm Medical Industries, Inc. | 895 Thousand USD | 27.164% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 5.48 Million USD | 88.124% |
| Reflect Scientific, Inc. | 2.66 Million USD | 75.575% |
| SmileDirectClub, Inc. | 597.06 Million USD | 99.891% |
| Sector 10, Inc. | 1000.00 USD | -65088.1% |
| Shandong Weigao Group Medical Polymer Company Limited | 4.74 Billion USD | 99.986% |
| SheerVision, Inc. | 837.56 Thousand USD | 22.17% |
| United Health Products, Inc. | 284.64 Thousand USD | -129.017% |
| Vasamed, Inc. | 1.6 Million USD | 59.264% |
| Wearable Health Solutions, Inc. | 223.17 Thousand USD | -192.097% |
| Yubo International Biotech Limited | 2.34 Million USD | 72.243% |